U.S. markets open in 2 hours 55 minutes
  • S&P Futures

    4,386.25
    +38.00 (+0.87%)
     
  • Dow Futures

    34,170.00
    +331.00 (+0.98%)
     
  • Nasdaq Futures

    15,121.50
    +112.00 (+0.75%)
     
  • Russell 2000 Futures

    2,204.80
    +28.00 (+1.29%)
     
  • Crude Oil

    71.04
    +0.75 (+1.07%)
     
  • Gold

    1,767.60
    +3.80 (+0.22%)
     
  • Silver

    22.57
    +0.37 (+1.65%)
     
  • EUR/USD

    1.1737
    +0.0010 (+0.08%)
     
  • 10-Yr Bond

    1.3090
    0.0000 (0.00%)
     
  • Vix

    22.94
    +2.13 (+10.24%)
     
  • GBP/USD

    1.3680
    +0.0021 (+0.15%)
     
  • USD/JPY

    109.5180
    +0.0980 (+0.09%)
     
  • BTC-USD

    43,129.78
    -1,745.35 (-3.89%)
     
  • CMC Crypto 200

    1,082.35
    -52.03 (-4.59%)
     
  • FTSE 100

    6,986.04
    +82.13 (+1.19%)
     
  • Nikkei 225

    29,839.71
    -660.34 (-2.17%)
     

IRTC APRIL 2 DEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against iRhythm Technologies, Inc.– IRTC

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, March 31, 2021 (GLOBE NEWSWIRE) -- Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of iRhythm Technologies, Inc. (NASDAQ: IRTC) between August 4, 2020 and January 28, 2021, inclusive (the “Class Period”).

To join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=irhythm-technologies-inc&id=2575 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email info@zhanginvestorlaw.com for information on the class action.

如果您想加入这个集体诉讼案,请在这里提交您的信息。http://zhanginvestorlaw.com/join-action-form/?slug=irhythm-technologies-inc&id=2575

If you wish to serve as lead plaintiff, you must move the Court before the April 2, 2021 DEADLINE. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that- iRhythm’s business would suffer as a result of the U.S. Centers for Medicare and Medicaid Services’ (“CMS”) rulemaking; reimbursement rates would in fact plummet; a lack of national pricing in the CMS rule and fee schedule would cause uncertainty and weakness in the Company’s business; and as a result of the foregoing, Defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

Lead plaintiff status is not required to seek compensation. You may retain counsel of your choice. You may remain an absent class member and take no action at this time.

Zhang Investor Law represents investors worldwide. Attorney Advertising. Prior results do not guarantee similar outcomes.

Zhang Investor Law P.C.
99 Wall Street, Suite 232
New York, New York 10005
info@zhanginvestorlaw.com
tel: (800) 991-3756